|
Name |
2-Propenal, 3-(2-furanyl)-2-methyl-
|
| Molecular Formula | C8H8O2 | |
| IUPAC Name* |
(Z)-3-(furan-2-yl)-2-methylprop-2-enal
|
|
| SMILES |
C/C(=C/C1=CC=CO1)/C=O
|
|
| InChI |
InChI=1S/C8H8O2/c1-7(6-9)5-8-3-2-4-10-8/h2-6H,1H3/b7-5-
|
|
| InChIKey |
ZNBXZUKDRRRQJK-ALCCZGGFSA-N
|
|
| Synonyms |
2-methyl-3(2-furyl)acrolein; FEMA No. 2704; 2-PROPENAL, 3-(2-FURANYL)-2-METHYL-; cinnamon acrolein; 65U4YZ14MX; alpha -Methylfurylacrolein; SCHEMBL1532601; ZINC1850921; AKOS000268597; .ALPHA.-METHYL-2-FURANACROLEIN; 2-FURANACROLEIN, .ALPHA.-METHYL-; METHYL-3-(2-FURYL)ACROLEIN, 2-; 3-(2-FURYL)-2-METHYLPROP-2-ENAL; 2-METHYL-3(2-FURYL)ACROLEIN [FHFI]; 2-METHYL-3-(.ALPHA.-FURYL)PROPENAL-2; 3-(2-(FURANYL)-2-METHYL-2-PROPENAL; .ALPHA.-METHYL-.BETA.-(2-FURYL)ACROLEIN; Q27263911
|
|
| CAS | 874-66-8 | |
| PubChem CID | 6435828 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 136.15 | ALogp: | 1.6 |
| HBD: | 0 | HBA: | 2 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 30.2 | Aromatic Rings: | 1 |
| Heavy Atoms: | 10 | QED Weighted: | 0.462 |
| Caco-2 Permeability: | -4.357 | MDCK Permeability: | 0.00002200 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.006 |
| Human Intestinal Absorption (HIA): | 0.008 | 20% Bioavailability (F20%): | 0.003 |
| 30% Bioavailability (F30%): | 0.002 |
| Blood-Brain-Barrier Penetration (BBB): | 0.351 | Plasma Protein Binding (PPB): | 90.80% |
| Volume Distribution (VD): | 2.002 | Fu: | 18.61% |
| CYP1A2-inhibitor: | 0.958 | CYP1A2-substrate: | 0.315 |
| CYP2C19-inhibitor: | 0.4 | CYP2C19-substrate: | 0.523 |
| CYP2C9-inhibitor: | 0.04 | CYP2C9-substrate: | 0.051 |
| CYP2D6-inhibitor: | 0.014 | CYP2D6-substrate: | 0.159 |
| CYP3A4-inhibitor: | 0.014 | CYP3A4-substrate: | 0.241 |
| Clearance (CL): | 9.323 | Half-life (T1/2): | 0.802 |
| hERG Blockers: | 0.017 | Human Hepatotoxicity (H-HT): | 0.46 |
| Drug-inuced Liver Injury (DILI): | 0.072 | AMES Toxicity: | 0.166 |
| Rat Oral Acute Toxicity: | 0.267 | Maximum Recommended Daily Dose: | 0.32 |
| Skin Sensitization: | 0.306 | Carcinogencity: | 0.856 |
| Eye Corrosion: | 0.975 | Eye Irritation: | 0.994 |
| Respiratory Toxicity: | 0.926 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000190 | ![]() |
0.548 | D01ZJK | ![]() |
0.204 | ||
| ENC000480 | ![]() |
0.429 | D03KOZ | ![]() |
0.194 | ||
| ENC000162 | ![]() |
0.351 | D0T3NY | ![]() |
0.190 | ||
| ENC001133 | ![]() |
0.325 | D0GY5Z | ![]() |
0.189 | ||
| ENC001629 | ![]() |
0.303 | D0U5QK | ![]() |
0.184 | ||
| ENC000189 | ![]() |
0.297 | D0E9CD | ![]() |
0.184 | ||
| ENC000678 | ![]() |
0.297 | D0PQ3G | ![]() |
0.181 | ||
| ENC000546 | ![]() |
0.286 | D06NVJ | ![]() |
0.178 | ||
| ENC001736 | ![]() |
0.283 | D0X9RY | ![]() |
0.178 | ||
| ENC003478 | ![]() |
0.269 | D07HBX | ![]() |
0.170 | ||